Nymox Pharmaceutical Corporation news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

NYMX 0.635 +0.008 (1.21%)
price chart
Class Action Lawsuit Filed Against Nymox Pharmaceutical Corporation and Paul ...
PHILADELPHIA, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Law Offices Bernard M. Gross, P.C. filed a class action lawsuit in the United States District Court, District of New Jersey, 14-cv-07331, on behalf of purchasers of NYMOX common stock between January ...
Related articles »  
Here's Why Nymox Nosedived Yesterday
Nymox is a biopharmaceutical that focuses on the development of novel therapeutics for the aging population. The company already has two products in the market - both being at-home tests. The first, called NicAlert, is used to test a person's smoking ...
Nymox Pharma (NYMX) Phase 3 Studies of NX-1207 Fail to Meet Primary ...  StreetInsider.com (subscription)
Nymox NX-1207 BPH Pivotal Phase 3 U.S. Studies NX02-0017 and NX02-0018 ...  GlobeNewswire (press release)
Related articles »  
Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation ...
26, 2014 /PRNewswire/ -- Cohen, Placitella & Roth, PC is investigating potential claims on behalf of investors who purchased Nymox Pharmaceutical Corporation ("Nymox" or "Company") NYMX, +6.36% during the period from January 31, 2011 through ...
Related articles »  
Rosen Law Firm Reminds Nymox Pharmaceutical Corporation Investors of ...
NEW YORK, Jan. 12, 2015 (GLOBE NEWSWIRE) -- The Rosen Law Firm reminds purchasers of Nymox Pharmaceutical Corporation common stock (Nasdaq:NYMX) during the period from January 31, 2011 through November 2, 2014, of the important January ...
Nymox Pharmaceutical Corporation Short Interest Update
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) reported a shortfall of 33,281 shares or 3.6% in the short interest. The remaining shorts are 3.7% of the total floated shares.
Mid-Day Changers: Nymox Pharmaceutical Corporation (NYMX), Clean Energy ...  WallStreet Scope
Robbins Arroyo LLP: Nymox Pharmaceutical Corporation (NYMX) Misled ...
SAN DIEGO and QUEBEC, Canada, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Nymox Pharmaceutical Corporation (Nasdaq:NYMX) has filed a federal securities fraud class action ...
Related articles »  
Company Shares of Nymox Pharmaceutical Corporation Drops by -9.36%
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has dropped 9.36% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 52.66% in the last 4 weeks.
Nymox Pharmaceutical Corporation Short Interest Disclosure
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) reported a drop of 4.8% or 43,158 shares in its short interest. The short figure came in at 3.5% of the total floats.
Share Price of Nymox Pharmaceutical Corporation Drops by -4.34%
Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has lost 4.34% during the past week and dropped 9.13% in the past 4 weeks. The shares are however, marginally negative as compared to the S&P 500 for the past week with a loss of 6.24%.
Share Price of Nymox Pharmaceutical Corporation Rally 56.1%
Shares of Nymox Pharmaceutical Corporation (NASDAQ:NYMX) rose by 56.1% in the past week and 64.1% for the last 4 weeks. In the past week, the counter has outperformed the S&P 500 by 56.53% and the outperformance increases to 55.56% for the last ...
Volatile Stocks: Nymox Pharmaceutical Corp , Skyworks Solutions Inc ...  Winston View
Closing Bell Reports: Nymox Pharmaceutical Corporation (NYMX), Discovery ...  WallStreet Scope